Patents by Inventor John R. Daniels

John R. Daniels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10707656
    Abstract: Pulling eyes are provided with integrated wiring systems suitable for installing conductors or cables. The pulling eyes may include body portions that define interior cavities that are sized to snugly engage outside portions of the conductors or cables. The body portions are sized to be deformably crimped onto the outside portions of the conductors or cables. The pulling eyes may also include head portions joined to the body portions, with the head portions defining apertures for receiving a strength member for installing the conductors or cables. These apertures place the interior cavities in communication with the exteriors of the pulling eyes.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: July 7, 2020
    Assignee: Southwire Company, LLC
    Inventors: John R. Carlson, David Brian McCardel, David A. Cooper, David Mercier, Philip Sasse, Allan W. Daniel, Timothy M. Andrea, Juan Alberto Galindo Gonzalez, Timmothy R. Bardin
  • Patent number: 10569988
    Abstract: Pulling eyes are provided with integrated wiring systems suitable for installing conductors or cables. The pulling eyes may include body portions that define interior cavities that are sized to snugly engage outside portions of the conductors or cables. The body portions are sized to be deformably crimped onto the outside portions of the conductors or cables. The pulling eyes may also include head portions joined to the body portions, with the head portions defining apertures for receiving a strength member for installing the conductors or cables. These apertures place the interior cavities in communication with the exteriors of the pulling eyes.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: February 25, 2020
    Assignee: Southwire Company, LLC
    Inventors: John R. Carlson, David Brian McCardel, David A. Cooper, David Mercier, Allan W. Daniel, Timothy M. Andrea
  • Patent number: 10554026
    Abstract: Pulling eyes are provided with integrated wiring systems suitable for installing conductors or cables. The pulling eyes may include body portions that define interior cavities that are sized to snugly engage outside portions of the conductors or cables. The body portions are sized to be deformably crimped onto the outside portions of the conductors or cables. The pulling eyes may also include head portions joined to the body portions, with the head portions defining apertures for receiving a strength member for installing the conductors or cables. These apertures place the interior cavities in communication with the exteriors of the pulling eyes.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: February 4, 2020
    Assignee: Southwire Company, LLC
    Inventors: John R. Carlson, David Brian McCardel, David A. Cooper, David Mercier, Philip Sasse, Allan W. Daniel, Timothy M. Andrea, Juan Alberto Galindo Gonzalez, Timmothy R. Bardin
  • Patent number: 7273896
    Abstract: This invention relates generally to compositions and systems for forming biomaterials containing a transient colorant for visualizing tissue or surgical materials coated with such biomaterials, to methods of using such compositions as bioadhesives, for tissue augmentation, in the prevention of surgical adhesions, for coating surfaces of synthetic implants, as drug delivery matrices, for ophthalmic applications, and in other applications.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: September 25, 2007
    Assignee: Angiotech Pharmaceuticals (US), Inc.
    Inventors: George Y. Daniloff, John R. Daniels
  • Patent number: 7029657
    Abstract: The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: April 18, 2006
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels, John R. Daniels
  • Patent number: 6960337
    Abstract: An improvement in a method of treating benign gynecological disorders is described. In the method, treatment of a benign gynecological disorder with a composition comprised of a gonadotropin releasing hormone (GnRH) compound and an estrogenic compound, and optionally, an androgenic compound, is extended to premenopausal women who are not receiving an exogenously supplied progestin on a regular or periodic basis. Treatment in accord with the invention does not increase significantly the risk of endometrial hyperplasia. The method is also suitable for contraception.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: November 1, 2005
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: Anne-Marie Daniels, John R. Daniels, Malcolm C. Pike, Darcy V. Spicer
  • Patent number: 6958142
    Abstract: A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic compound in the form of a water-soluble complex with a water-soluble cyclodextrin. The preparation effectively suppresses ovarian estrogen and progesterone production, and prevents signs and symptoms of estrogen deficiency, without a significant increase in the risk of endometrial hyperplasia.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: October 25, 2005
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: John R. Daniels, Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels
  • Publication number: 20040202625
    Abstract: This invention relates generally to compositions and systems for forming biomaterials containing a transient colorant for visualizing tissue or surgical materials coated with such biomaterials, to methods of using such compositions as bioadhesives, for tissue augmentation, in the prevention of surgical adhesions, for coating surfaces of synthetic implants, as drug delivery matrices, for ophthalmic applications, and in other applications.
    Type: Application
    Filed: April 10, 2003
    Publication date: October 14, 2004
    Inventors: George Y. Daniloff, John R. Daniels
  • Publication number: 20040023867
    Abstract: An improvement in a method of treating benign gynecological disorders is described. In the method, treatment of a benign gynecological disorder with a composition comprised of a gonadotropin releasing hormone (GnRH) compound and an estrogenic compound, and optionally, an androgenic compound, is extended to premenopausal women who are not receiving an exogenously supplied progestin on a regular or periodic basis. Treatment in accord with the invention does not increase significantly the risk of endometrial hyperplasia. The method is also suitable for contraception.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 5, 2004
    Inventors: Anna-Marie Daniels, John R. Daniels, Malcolm C. Pike, Darcy V. Spicer
  • Publication number: 20040022739
    Abstract: A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic compound in the form of a water-soluble complex with a water-soluble cyclodextrin. The preparation effectively suppresses ovarian estrogen and progesterone production, and prevents signs and symptoms of estrogen deficiency, without a significant increase in the risk of endometrial hyperplasia.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 5, 2004
    Inventors: John R. Daniels, Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels
  • Publication number: 20040022738
    Abstract: The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 5, 2004
    Inventors: Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels, John R. Daniels
  • Publication number: 20010016578
    Abstract: Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
    Type: Application
    Filed: May 1, 2001
    Publication date: August 23, 2001
    Applicant: Balance Pharmaceuticals, Inc.
    Inventors: Darcy V. Spicer, Malcolm Cecil Pike, John R. Daniels
  • Patent number: 6225298
    Abstract: Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: May 1, 2001
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: Darcy V. Spicer, Malcolm Cecil Pike, John R. Daniels
  • Patent number: 5653758
    Abstract: A temporarily implantable organ displacement implant is comprised of a bladder with a one-way valve for being filled with a fluid for displacement of a healthy organ from a tissue site desired to be irradiated by radiation therapy. This organ displacement implant is substantially radiolucent which thereby facilitates its placement and minimizes its interference with the radiation therapy.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 5, 1997
    Assignee: LipoMatrix, Incorporated
    Inventors: John R. Daniels, Terry R. Knapp
  • Patent number: 5226970
    Abstract: Process for the remanufacture of transformers of the type having a coil/core assembly immersed in a tank of mineral oil. Contaminants such as water, air and dirt are removed from the coil/core assembly by means of a hot mineral oil bath which is maintained in a temperature range between the boiling point of water and the boiling point of the mineral oil, typically 212.degree. F. to 295.degree. F.
    Type: Grant
    Filed: May 1, 1991
    Date of Patent: July 13, 1993
    Assignee: General Signal Corporation
    Inventors: David A. Barnett, John R. Daniels, Sr.
  • Patent number: 5135494
    Abstract: A catheter device for accessing an internal body site along a small-diameter vessel path containing branch points in which the path may follow either the larger of smaller-diameter branch vessels. The device includes a catheter having a distal-end inflatable balloon and an distal-end aperture. A guide wire in the device is designed to partially block the aperture at one or more axial wire positions, allowing the balloon to be inflated by fluid infusion into the catheter. In a catheter placement operation, the catheter is advanced along the vessel path toward the selected target site. When the leading end of the catheter encounters a branch point at which the path follows the larger-diameter vessel, the guide wire is moved to a position which partially blocks the catheter aperture, and fluid is infused into the catheter to inflate the balloon. The catheter is then carried by hydrodynamic flow into the larger-diameter vessel.
    Type: Grant
    Filed: November 18, 1991
    Date of Patent: August 4, 1992
    Assignee: Target Therapeutics
    Inventors: Erik T. Engelson, John R. Daniels
  • Patent number: 4813934
    Abstract: A catheter device for accessing an internal body site along a small-diameter vessel path containing branch points in which the path may follow either the larger of smaller-diameter branch vessels. The device includes a catheter having a distal-end inflatable ballon and a distal-end aperture. A guide wire in the device is designed to block the aperture at one or more axial wire positions, allowing the balloon to be inflated by fluid infusion into the catheter. In a catheter placement operation, the catheter is advanced along the vessel path toward the selected target site. When the leading end of the catheter encounters a branch point at which the path follows the larger-diameter vessel, the guide wire is moved to a position which blocks the catheter aperture, and fluid is infused into the catheter to inflate the balloon. The catheter is then carried by hydrodynamic flow into the larger-diameter vessel.
    Type: Grant
    Filed: August 7, 1987
    Date of Patent: March 21, 1989
    Assignee: Target Therapeutics
    Inventors: Erick T. Engelson, John R. Daniels
  • Patent number: 4725671
    Abstract: Collagen membranes with desired properties are prepared by using a variety of gel-forming techniques in combination with methods for converting the gels to solid forms. The properties of these membranes or other solid forms may be further altered by cross-linking the collagen preparation either after formation of the membrane or gel, or most preferably by mixing cross-linked collagen with solubilized collagen in the original mixture used to create the gel.
    Type: Grant
    Filed: February 4, 1986
    Date of Patent: February 16, 1988
    Assignee: Collagen Corporation
    Inventors: George Chu, John R. Daniels
  • Patent number: 4708718
    Abstract: A method of treating a solid tumor, including the steps of localizing the tumor and the arterial vessel that supplies it, and injecting into the vessel, a vaso-occlusive collagen material adapted to produce occlusion of vessels having lumen diameters between about 10 and 150 microns. The injected material is effective to produce occlusion of the secondary and tertiary vessels supplying the tumor, distal to the collateral blood vessels which may also supply the tumor. The region of the occluded tumor is heated under conditions that produce tissue necrosis selectively in the occluded tumor tissue.
    Type: Grant
    Filed: July 2, 1985
    Date of Patent: November 24, 1987
    Assignee: Target Therapeutics
    Inventor: John R. Daniels
  • Patent number: 4655746
    Abstract: A catheter device for transferring fluid material to or from one or more selected-length segment of a vessel. The device includes first and second catheters, each having a tube with distal and proximal ends, an inflatable balloon carried on the tube, adjacent the distal tube end, and a fluid conduit for supplying the balloon, with such operatively positioned in the vessel. A central region of the second-catheter tube is axially shiftable within the first-catheter tube, allowing the balloons to be placed at desired relative positions in the vessel. Fluid is injected into the region between the two balloons through a fluid passageway formed in a channel in the first-catheter tube.
    Type: Grant
    Filed: December 2, 1985
    Date of Patent: April 7, 1987
    Assignee: Target Therapeutics
    Inventors: John R. Daniels, Erik T. Engelson, Garbriel B. Vegh